ADAC HealthCare Information Systems (HCIS) moved to strengthen its burgeoning PACS efforts this month by signing an agreement with global information technology services firm Perot Systems. The multiyear deal stipulates that Dallas-based Perot will
ADAC HealthCare Information Systems (HCIS) moved to strengthen its burgeoning PACS efforts this month by signing an agreement with global information technology services firm Perot Systems. The multiyear deal stipulates that Dallas-based Perot will provide ADAC HCIS of Houston with professional and implementation services for ADACs QuadRIS radiology information system and Envoi PACS products. Perot will furnish ADAC clients with system integration, network design, clinical process reengineering, and Web technology support.
Introduced at 1998s RSNA meeting, Envoi is based on QuadRIS, and allows physicians to distribute images and data using Web-based technology (SCAN 1/20/99). Envoi also includes Physicians Desktop, Intranet Image Server, DICOM Acquisition, VR SoftView diagnostic and clinical review workstations, VR SoftStore and HardStore archive, and Workflow Manager. The products architecture combines Oracles relational database technology and Windows client/server software.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
Could an Emerging PET Tracer be a Game Changer for Detecting Hepatocellular Carcinoma?
June 23rd 2025In addition to over 90 percent sensitivity in detecting hepatocellular carcinoma (HCC), the glypican-3 (GPC3) targeted PET tracer 68Ga-aGPC3-scFv appeared to be advantageous in identifying HCC tumors smaller than one centimeter, according to pilot study findings presented at the SNMMI conference.
SNMMI: What a New Meta-Analysis Reveals About Radiotracers for PET/CT Detection of PCa
June 22nd 2025While (68Ga)Ga-PSMA-11 offers a pooled sensitivity rate of 92 percent for prostate cancer, (18F)-based radiotracers may offer enhanced lesion detection as well as improved imaging flexibility, according to a meta-analysis presented at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.